Conference Coverage

Cardiovascular risk in type 2 diabetes: Patients are often clueless


 

REPORTING FROM ACC 2018


Encouragingly though, more than 80% of the type 2 diabetes patients who hadn’t realized they were at increased cardiovascular risk indicated that if they truly are at increased risk, they would take preventive measures to reduce that risk, including dietary modification and a conversation with their healthcare provider. In addition, 80% said their motivation in doing so would be to improve their quality of life, and 73% cited a desire to live longer and spend more time with their family, Dr. Pak observed.

“The findings from this survey highlight a huge opportunity to educate and inform, and for patients and their loved ones to act on,” he said.

The For Your Sweetheart survey was supported by Boehringer Ingelheim, Eli Lilly, and the Company Diabetes Alliance.

SOURCE: Pak J. ACC 18.

Pages

Recommended Reading

ODYSSEY Outcomes results build on FOURIER
MDedge Family Medicine
ODYSSEY Outcomes trial redefines secondary cardiovascular prevention
MDedge Family Medicine
Ticagrelor noninferior to clopidogrel in terms of major bleeds in STEMI
MDedge Family Medicine
Genotype did not significantly affect evacetrapib response
MDedge Family Medicine
CECCY: Carvedilol didn’t curb cardiotoxicity in breast cancer patients
MDedge Family Medicine
MDedge Daily News: Improving wearable cardioverter defibrillators
MDedge Family Medicine
MOMENTUM 3 HeartMate 3 LVAD ‘practice changing’
MDedge Family Medicine
Barbershop intervention cuts blood pressure in black men
MDedge Family Medicine
VIDEO: Patient vouchers prompt physicians to prescribe top antiplatelet drugs
MDedge Family Medicine
Statins, ACE inhibitors linked to fetal cardiac anomalies
MDedge Family Medicine